Caligan Partners LP - Dec 31, 2024 SCHEDULE 13G Report for Verrica Pharmaceuticals Inc. Common stock, $0.0001 par value per share (VRCA)

Filing Manager: Caligan Partners LP
Reporting Manager: Caligan Partners LP
Security: Verrica Pharmaceuticals Inc. Common stock, $0.0001 par value per share
Symbol: VRCA
Shares outstanding: 159M shares
Disclosed Ownership: 15.9M shares
Ownership: 9.99%
Form type: SCHEDULE 13G
Date filed: 2/12/2025, 04:05 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Caligan Partners LP	9.99%	15.9M	0	15.9M	/s/ David Johnson	David Johnson, Managing Partner
David Johnson	9.99%	15.9M	0	15.9M	/s/ David Johnson	David Johnson, Individually